Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Receivables (2016 - 2025)

iBio (IBIO) has disclosed Change in Receivables for 13 consecutive years, with $65000.0 as the latest value for Q3 2025.

  • Quarterly Change in Receivables changed N/A to $65000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Dec 2025, up 106.71% year-over-year, with the annual reading at -$1.0 million for FY2023, 212.87% down from the prior year.
  • Change in Receivables for Q3 2025 was $65000.0 at iBio, up from -$69000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $893000.0 in Q1 2022, with the low at -$900000.0 in Q1 2023.
  • Average Change in Receivables over 4 years is $24818.2, with a median of $54000.0 recorded in 2022.
  • The sharpest move saw Change in Receivables skyrocketed 329.33% in 2022, then tumbled 1625.0% in 2023.
  • Over 4 years, Change in Receivables stood at -$96000.0 in 2021, then increased by 11.46% to -$85000.0 in 2022, then increased by 18.82% to -$69000.0 in 2023, then soared by 194.2% to $65000.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $65000.0, -$69000.0, and -$900000.0 for Q3 2025, Q2 2023, and Q1 2023 respectively.